Elite Pharmaceuticals, Inc. (OTCMKTS:ELTP – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $0.75 and last traded at $0.60, with a volume of 20266379 shares traded. The stock had previously closed at $0.71.
Elite Pharmaceuticals Stock Performance
The company’s 50-day moving average price is $0.35 and its two-hundred day moving average price is $0.23. The company has a market capitalization of $640.96 million, a price-to-earnings ratio of 70.50 and a beta of 0.19. The company has a debt-to-equity ratio of 0.08, a current ratio of 3.08 and a quick ratio of 2.09.
About Elite Pharmaceuticals
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
See Also
- Five stocks we like better than Elite Pharmaceuticals
- What is Put Option Volume?
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- Options Trading – Understanding Strike Price
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for Elite Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elite Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
